Angene Chemical
Draw
|
Currency :
Home Products

AG00H845

957054-30-7 | 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine

Chemical structure of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, CAS 957054-30-7
AG00H845
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 957054-30-7
Catalog Number AG00H845(AGN-PC-0W5CAQ)
Chemical Name 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine
IUPAC Name 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine
InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)
InChI Key LHNIIDJUOCFXAP-UHFFFAOYSA-N
MDL Number MFCD11616196
Molecular Formula C23H27N7O3S2
Molecular Weight 513.6356
SMILES N1N=CC2=C(C=CC=C12)C=1N=C(C2=C(N1)C=C(S2)CN2CCN(CC2)S(=O)(=O)C)N2CCOCC2
UNII ICY00EMP8P
Synonyms
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine, GDC 0941, GDC-0941, GDC0941, pictilisib, GDC-0941, 957054-30-7, PICTILISIB, Pictrelisib, GDC0941, GDC 0941, 4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine, 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, UNII-ICY00EMP8P, Pictilisib (GDC-0941), ICY00EMP8P, CHEBI:65326, RG7321, AK-40872, 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine, 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine, C23H27N7O3S2, 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-(morpholin-4-yl)thieno[3,2-d]pyrimidine, 2-(1h-Indazol-4-Yl)-6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Yl-Thieno[3,2-D]pyrimidine, 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine, GD9, Thieno(3,2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl]methyl)-4-(4-morpholinyl)-, Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-, Pictilisib [USAN:INN], Pictilisib (USAN), Kinome_3719, PubChem16427, GDC0941(Pictilisib), 957054-50-1, Pictilisib; GDC-0941, cc-29, MLS006010057, SCHEMBL190812, CHEMBL521851, GTPL5682, BDBM25028, CTK8B8042, DTXSID40241930, EX-A167, SYN1041, LHNIIDJUOCFXAP-UHFFFAOYSA-N, HMS2043A16, HMS3244H06, HMS3244H10, HMS3244H14, HMS3265I05, HMS3265I06, HMS3265J05, HMS3265J06, HMS3654K13, AOB87310, BCP01714, EX-A1536, GNE 0941, KS-000006NA, GDC-0941/GDC0941, ABP000080, ANW-59256, MFCD11616196, RS0072, s1065, ZINC16052714, AKOS015966503, AN-5296, BCP9000715, CS-0081, DB11663, QC-4780, RG-7321, SB19941, NCGC00187482-01, NCGC00187482-03, NCGC00187482-10, 2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine, 4CA-0560, AJ-68088, AS-19377, BC657908, HY-50094, SC-85717, SMR004701219, AB0033712, AX8167199, TC-148001, FT-0696889, ST24039079, SW202556-4, X7409, EC-000.2335, D10189, Q-3925, 054G307, A845396, J-513238, BRD-K52911425-001-02-3, C532162000, Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4, 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidi, 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidine, 4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine, 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonyl-1-piperazinyl)methyl]-4-thieno[3,2-d]pyrimidinyl]morpholine, 4-{6-[(4-methanesulfonylpiperazin-1-yl)methyl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl}-1H-indazole, Thieno[3,2-d]pyrimidine,2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-, Pictrelisib [INN], D08QGT, D0T1ZO, GDC-941, GDC-0941, GDC0941, A8210, A10421, A11168, C532162, Thieno[3,2-d]pyrimidine,2- -6-[[4- -1-piperazinyl]methyl]-4- -, 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine, Pictilisib, 98%, a potent inhibitor of PI3Kalpha/delta - 100MG 100mg, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine, 957054-33-0,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited